FoRx Therapeutics
PrivateLast Round
Series A
Dec 18, 2025
Total Funding Raised
$60.85M
Company Overview
FoRx Therapeutics is a biotechnology company that develops a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FoRx Therapeutics Comps
Public and private peers based on sector, stage, and business model.
FoRx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 18, 2025 | ||||
| Seed | Apr 22, 2020 |
FoRx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Omega Funds | Seed |
| EQT Life Sciences | Series A |
| Novartis Venture Fund | Series A, Seed |
| Pfizer Ventures | Seed, Series A |
| Pfizer | Seed, Series A |
| M Ventures | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 26, 2026
FORX-428 shows potential for best-in-class PARG inhibition.
- Mar 26, 2026
Presented preclinical data for FORX-428 at ACS Spring 2026.
FoRx Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about FoRx Therapeutics's valuation, stock price, and market status.
